Revlon
This article was originally published in The Rose Sheet
Executive Summary
Stephanie Klein-Peponis tapped as exec VP, chief marketing officer, effective immediately, Revlon announces. Exec promoted from role as exec VP, chief planning and business development officer, a position she has held since June (1"The Rose Sheet" June 2, 2003, In Brief). Klein-Peponis succeeds Chief Marketing Officer Debra Leipman-Yale, who is leaving the company after serving during a transitional period, firm notes...
You may also be interested in...
Revlon VP
Stephanie Klein Peponis to newly-created position of exec VP, chief planning and business development officer effective June 2, Revlon announces. Former VP and director of Boston Consulting Group will be responsible for supporting ongoing development and refinement of Revlon's business strategy, firm says. Reporting to CEO Jack Stahl, she will oversee planning processes, market research and analysis and evaluate new growth opportunities...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.